MedPath

(PREVENT)A Randomized, Double-blind, Placebo-controlled Trial on the Prevention of Chronic Postoperative Pain after Inguinal Hernia and Knee Surgery by Postoperative Treatment with Tapentadol

Phase 1
Conditions
chronic postoperative pain
Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Registration Number
CTIS2024-511010-21-00
Lead Sponsor
eids Universitair Medisch Centrum (LUMC)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
540
Inclusion Criteria

American Society of Anesthesiologists score 1, 2 or 3, Age between 18-80 years

Exclusion Criteria

Chronic pain due to any cause other than pain caused by osteoarthritis of the knee or inguinal hernia which in the opinion of the investigator may influence the outcome of the trial;, Regular use of anti-depressants or anti-epileptics for chronic pain. If this medica-tion is used for another indication than pain participation in the study is allowed., Known allergies or contraindication to the study medication according to the SmPC (such as the presence of respiratory depression, severe astma, paralytic ileus and acute intoxications with alcohol, hypnotics or other psychotropic active substances);, Pregnancy/lactation;, Use of MAO-inhibitors or rifampicin within the last 14 days before inclusion;, Inability to perform psychophysical testing (eg. in case of cognitive or psychiatric disorders, Inability to give informed consent, Inability to communicate with the investigators

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath